Weight loss, dementia and ataxia susceptible to doxycycline: A likely new case report caused by T.whipplei

Revue de Medecine Interne

Volumn 34, Issue 10, 2013, Pages 641-644

  Lagier, J C ^a,b   Fenollar, F ^a,b   Koric, L ^b   Guedj, E ^a   Ceccaldi, M ^b   Raoult, D ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

18FDG PET; Doxycyclin; Tropheryma whipplei; Whipple's disease

Indexed keywords

DOXYCYCLINE; FLUORODEOXYGLUCOSE F 18; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; ATAXIA; BACTERIUM IDENTIFICATION; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DEMENTIA; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HUMAN; INTESTINE LIPODYSTROPHY; MALE; NEUROLOGIC DISEASE; NONHUMAN; OBESITY; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; SALIVA ANALYSIS; SEROLOGY; TROPHERYMA WHIPPELII; WEIGHT REDUCTION; WESTERN BLOTTING; (18)FDG-PET; DRUG EFFECT; MALADIE DE WHIPPLE; MIDDLE AGED; PET-SCANNER AU (18)FDG; PHYSIOLOGY; TROPHERYMA; TROPHERYMA WHIPPLEI; WEIGHT GAIN;

(18)FDG-PET; DOXYCYCLIN; DOXYCYCLINE; MALADIE DE WHIPPLE; PET-SCANNER AU (18)FDG; TROPHERYMA WHIPPLEI; WHIPPLE'S DISEASE;

ANTI-BACTERIAL AGENTS; ATAXIA; DEMENTIA; DOXYCYCLINE; HUMANS; MALE; MIDDLE AGED; OBESITY; TROPHERYMA; WEIGHT GAIN; WHIPPLE DISEASE;

EID: 84885372336     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2012.12.006     Document Type: Article

References (26)

1. Lagier J.C., Lepidi H., Raoult D., et al. Systemic Tropheryma whipplei: clinical presentation of 142patients with infections diagnosed or confirmed in a reference center. Medicine (Baltimore) 2010, 89:337-345.
2. Gerard A., Sarrot-Reynauld F., Liozon E., et al. Neurologic presentation of Whipple disease: report of 12cases and review of the literature. Medicine (Baltimore) 2002, 81:443-457.
3. Pierrot-Deseilligny Despujol C., Pouchot J., Trad S. Il en avait gros sur le cœur!. Rev Med Interne 2011, 32:710-713.
4. Panegyres P.K., Edis R., Beaman M., et al. Primary Whipple's disease of the brain: characterization of the clinical syndrome and molecular diagnosis. QJM 2006, 99:609-623.
5. Fenollar F., Nicoli F., Paquet C., et al. Progressive dementia associated with ataxia or obesity in patients with Tropheryma whipplei encephalitis. BMC Infect Dis 2011, 11:171.
6. Blanc F., Ben A.K., Schramm F., et al. Whipple limbic encephalitis. Arch Neurol 2011, 68:1471-1473.
7. Donmez F.Y., Ulu E., Basaran C., et al. MRI of recurrent isolated cerebral Whipple's disease. Diagn Interv Radiol 2010, 16:112-115.
8. Raheja A.A., Lui Y.W., Pinzon-Ardila A., et al. Use of diffusion-weighted imaging in recurrent central nervous system Whipple's disease: a case report and review of the literature. Clin Imaging 2010, 34:143-147.
9. Wintenberger C., Bosseray A., Colombe B., et al. Whipple's disease: a curable encephalitis. Rev Med Interne 2011, 32:513-516.
10. Yu C., Jiang A., Yu Y. Serial imaging changes of cerebral Whipple's disease: from onset to the end. J Neuroimaging 2007, 17:81-83.
11. Mohamed W., Neil E., Kupsky W.J., et al. Isolated intracranial Whipple's disease - report of a rare case and review of the literature. J Neurol Sci 2011, 308:1-8.
12. Pauletti C., Pujia F., Accorinti M., et al. An atypical case of neuro-Whipple: clinical presentation, magnetic resonance spectroscopy and follow-up. J Neurol Sci 2010, 297:97-100.
13. Louis E.D., Lynch T., Kauffmann P., et al. Diagnostic guidelines in central nervous system Whipple's disease. Ann Neurol 1996, 40:561-568.
14. Black D.F., Aksamit A.J., Morris J.M. MR imaging of central nervous system Whipple disease: a 15-year review. AJNR Am J Neuroradiol 2010, 31:1493-1497.
15. Lepidi H., Fenollar F., Gerolami R., et al. Whipple's disease: immunospecific and quantitative immunohistochemical study of intestinal biopsy specimens. Hum Pathol 2003, 34:589-596.
16. Fenollar F., Trani M., Davoust B., et al. Prevalence of asymptomatic Tropheryma whipplei carriage among humans and non-human primates. J Infect Dis 2008, 197:880-887.
17. Lagier J.C., Fenollar F., Lepidi H., et al. Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple's disease. J Antimicrob Chemother 2010, 65:2005-2012.
18. Feurle G.E., Junga N.S., Marth T. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease. Gastroenterology 2010, 138:478-486.
19. Feurle G.E., Moos V., Schneider T., et al. The combination of chloroquine and minocycline, a therapeutic option in cerebrospinal infection of Whipple's disease refractory to treatment with ceftriaxone, meropenem and co-trimoxazole. J Antimicrob Chemother 2012, 67:1295-1296.
20. Bakkali N., Fenollar F., Biswas S., et al. Acquired resistance to trimethoprim-sulfamethoxazole during Whipple disease and expression of the causative target gene. J Infect Dis 2008, 198:101-108.
21. Fenollar F., Rolain J.M., Alric L., et al. Resistance to trimethoprim/sulfamethoxazole and Tropheryma whipplei. Int J Antimicrob Agents 2009, 34:255-259.
22. Lagier J.C., Fenollar F., Lepidi H., et al. Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease. J Antimicrob Chemother 2011, 66(1):188-189.
23. Lagier J.C., Fenollar F., Halle O., et al. Efficacy of antibiotic therapy in polyarthritis: a clue suggesting Whipple's disease. Int J Antimicrob Agents 2009, 34:389-390.
24. Greub G. A new piece added to the whipple puzzle: Tropheryma whipplei primary infection with bacteremia and cough. Clin Infect Dis 2010, 51:522-524.
25. Dobbins W.I. Whipple's disease 1987, Thomas Books, Springfield, IL ed.
26. Fenollar F., Amphoux B., Raoult D. A paradoxical Tropheryma whipplei western blot differentiates patients with whipple disease from asymptomatic carriers. Clin Infect Dis 2009, 49:717-723.